side effects bpc-157 Effects: What Research Shows BPC-157: Tendon Repair and More

In conclusion, presenting the decompression/reperfusion period as one of severe vascular and multiorgan failure, and particularly decompression/reperfusion -occlusion/occlusion like-syndrome, BPC 157 therapy exerts a particular action to organize the bypassing of the defect, blood flow re-establishing, and reorganization to compensate vascular defects and/or reverse induced failure [8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25]

Vorsicht brigens, wenn man an sportlichen Wettkmpfen mit Dopingkontrollen teilnimmt: BPC-157 steht auf der WADA-Liste verbotener Substanzen (genau wie TB-500 brigens)

it cannot tolerate systematic neglect

10.1016/j.bpj.2022.10.037 104 MartinkovV.TrkaF.VojtekB.MllerP

Statin therapy was the only significant risk factor for progression

The consistently low level of Glx/Cr, NAA/Cr and Lipid/Cr in R1.40 upon demyelination indicates change of brain chemistry that could be a result of diffuse axonal damage and/or metabolic shift (73, 74)